The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Chromatin modifications on plasma ctDNA as a tool to phenotype castration-resistant prostate cancer.
 
Asli Munzur
No Relationships to Disclose
 
Joonatan Sipola
No Relationships to Disclose
 
Clara Seo
Employment - New York Cancer and Blood Specialists (I)
 
Edmond Michael Kwan
Honoraria - Astellas Pharma; Ipsen; Janssen; Research Review
Consulting or Advisory Role - Astellas Pharma; Ipsen; Janssen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Pfizer; Roche
 
Karan Parekh
No Relationships to Disclose
 
Cecily Q. Bernales
No Relationships to Disclose
 
Gráinne Donnellan
No Relationships to Disclose
 
Ingrid Bloise
No Relationships to Disclose
 
Gillian Vandekerkhove
Research Funding - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences
 
Matti Annala
Leadership - Fluivia
Stock and Other Ownership Interests - Fluivia
 
Corinne Maurice Dror
No Relationships to Disclose
 
Kim N. Chi
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; POINT Biopharma; Roche
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Constellation Pharmaceuticals; Daiichi Sankyo; ESSA; Janssen; Merck; POINT Biopharma; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); ESSA (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Expert Testimony - AstraZeneca; Novartis
 
Cameron Herberts
No Relationships to Disclose
 
David Yoshio Takeda
Stock and Other Ownership Interests - Merck; Pfizer
 
Alexander William Wyatt
Honoraria - Astellas Pharma; AstraZeneca; AstraZeneca Canada; Janssen; Merck
Consulting or Advisory Role - AstraZeneca
Research Funding - ESSA (Inst)